Addus HomeCare (NASDAQ:ADUS) Reports Q2 CY2026 In Line With Expectations
Home healthcare provider Addus HomeCare NASDAQ:ADUS met Wall Street’s revenue expectations in Q2 CY2026, with sales up 8% year on year to $377.4 million. Its non-GAAP profit of $1.73 per share was 1.9% above analysts’ consensus estimates.Addus HomeCare (ADUS) Q2 CY2026 Highlights:Company OverviewSe…